SUNPHARMA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sun Pharmaceutical Industries Ltd

Watchlist Manager

Watchlist

Price: 1 779.2 INR -0.54% Market Closed

Market Cap: ₹4.3T

	Sun Pharmaceutical Industries Ltd NSE:SUNPHARMA	IN
	Nintendo Co Ltd OTC:NTDOY	JP
	Compagnie Lebon SA PAR:ALBON	FR
	Medistim ASA F:MD1	NO
	Basic Fit NV AEX:BFIT	NL
	Ansell Ltd ASX:ANN	AU
	Korea Zinc Inc KRX:010130	KR
E	Elis SA SWB:7EL	FR
	Paramount Global NASDAQ:PARA	US
	Swatch Group AG F:UHR	CH
C	Constellation Brands Inc F:CB1A	US
S	Societe BIC SA OTC:BICEF	FR
	Uniti Group Ltd ASX:UWL	AU
J	Juva Life Inc OTC:JUVAF	CA
G	Gilead Sciences Inc MIL:GILD	US

Profitability Summary

Sun Pharmaceutical Industries Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

78%

Gross Margin is Increasing

73% > 80%

Healthy Operating Margin

24%

Sustainable 3Y Average Operating Margin

23%

Operating Margin is Increasing

21% > 24%

Healthy Net Margin

19%

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

19% > 19%

Exceptional Free Cash Flow Margin

16%

Strong 3Y Average Free Cash Flow Margin

19%

Free Cash Flow Margin is Increasing

8% > 16%

Positive ROE

15%

Positive 3Y Average ROE

Positive 3Y Average ROIC

16%

Declining ROIC

15% > 15%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.